Literature DB >> 8972886

Insulin resistance and cardiovascular complications in patients with essential hypertension.

K Kamide1, M Nagano, N Nakano, Y Yo, R Kobayashi, H Rakugi, J Higaki, T Ogihara.   

Abstract

Hyperinsulinemia or insulin resistance is suggested to play a role in the pathogenesis of hypertension and its target organ diseases. We designed this study to evaluate the role of insulin resistance in cardiac function, cardiac hypertrophy, wall thickness of the common carotid artery, and endothelial function of the brachial artery in essential hypertensive patients without diabetes mellitus. Insulin resistance was evaluated by the constant glucose infusion rate (M value) during the euglycemic-hyperinsulinemic glucose clamp test. In correlation analysis for several indices of glucose metabolism, only M value correlated with left ventricular mass index (LVMI), ratio of peak velocity during atrial contraction to that during early left ventricular filling phase (E/A ratio) and intima-media complex (IMC). In stepwise regression analysis of various risk factors for cardiovascular diseases, only M value and age were dependent factors for LVMI, E/A ratio, and IMC. No indices of glucose metabolism or risk factors for cardiovascular diseases correlated with endothelium-dependent and -independent vasodilation. These results suggest that insulin resistance, but not glucose intolerance and hyperinsulinemia, partly accelerates cardiovascular complications such as left ventricular hypertrophy and wall thickening of the carotid artery in patients with essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8972886     DOI: 10.1016/s0895-7061(96)00263-4

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  5 in total

Review 1.  Earlier management of subjects who are prone to hypertension and diabetes mellitus.

Authors:  Hiromi Rakugi; Toshio Ogihara
Journal:  Curr Diab Rep       Date:  2004-04       Impact factor: 4.810

Review 2.  Vascular signaling pathways in the metabolic syndrome.

Authors:  Hiromi Rakugi; Kei Kamide; Toshio Ogihara
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

3.  Profound hyperglycemia in knockout mutant mice identifies novel function for POU4F2/Brn-3b in regulating metabolic processes.

Authors:  Stavroula Bitsi; Houda Ali; Lauren Maskell; Samir Ounzain; Vidya Mohamed-Ali; Vishwanie S Budhram-Mahadeo
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-12-15       Impact factor: 4.310

Review 4.  The metabolic syndrome and its relationship to hypertensive target organ damage.

Authors:  Giuseppe Mulè; Giovanni Cerasola
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-03       Impact factor: 3.738

Review 5.  Endothelial dysfunction in diabetes mellitus.

Authors:  Hadi A R Hadi; Jassim Al Suwaidi
Journal:  Vasc Health Risk Manag       Date:  2007
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.